This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greenberg: Risk Finally Catches Up With IBM

NEW YORK (TheStreet) -- In July 2012, when IBM's (IBM - Get Report) stock was about where it is today, I wrote a piece headlined, "Is Wall Street Ignoring Risk at IBM?."

As it turns out, it was. IBM's stock soared to a high of around $215 from $186 on the day the piece ran, which is higher than it is today.

All investors cared about was that the company beat earnings and it that wasn't veering from its so-called 2015 "roadmap," which is supposed to deliver earnings per share of $20.

A not-so-funny-thing happened on the road to shareholder bliss: The company's sales growth didn't just stall, but for the past six quarters has shifted into reverse. (Interesting how the sales slippage almost correlates perfectly with Sam Palmisano's departure as CEO. At the time, some of us -- OK, yours truly -- wondered if he was getting out while the getting was good. But I digress...)

Must Read: Jim Cramer's 6 Stocks in 60 Seconds: CLB PPG NUE ALKS DDD CLX

After quarters of pretending not to notice, with last night's sales miss, investors are finally paying attention.

To quote UBS analyst Steve Milunovich, "Credibility is at a low."

Bernstein analyst Toni Saccanoghi wonders whether IBM is "broken."

A better question: Outside of pulling levers like share buybacks and acquisitions, was it ever really fixed?

There's no question that IBM, under Palmisano and Gerstner, didn't stand still and become a template for Dell. It moved ambitiously into software and it made a bunch of acquisitions away from its legacy hardware business. The company would tell skeptics that it is now run for cash, with profits reinvested in the business.

And in a stroke of brilliance, it created a highly effective investor relations marketing strategy, creating a five-year "roadmap" to hit a specific earnings per share target. The 2015 roadmap calls for earnings per share of $20.

Not only did that give the company a long-term target to tantalize investors with, but it went so far as to say which levers it will pull to get there: Buybacks, acquisitions and "operating leverage."

I'm not a fan of long-term public stock targets, because so much can happen between here and there. And, indeed, that's what is happening with IBM. Investors have finally figured out that earnings per share growth on zero or negative sales growth can only go so far. Best case, it suggest low quality earnings; worst case, earnings growth that isn't sustainable.

  1 2

Herb Greenberg, editor of Herb Greenberg's Reality Check, is a contributor to CNBC. He does not own shares, short or trade shares in an individual corporate security.


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Herb's Tweets

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs